Absci reports first quarter 2022 financial and operating results

Vancouver, wash., may 11, 2022 (globe newswire) -- absci corporation (nasdaq: absi), the drug and target discovery company harnessing deep learning ai and synthetic biology to expand the therapeutic potential of proteins, today reported financial and operating results for the quarter ended march 31, 2022.
ABSI Ratings Summary
ABSI Quant Ranking